CHE

Chemed Corp
NYSEHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$6.84B
P/E Ratio
25.29
EPS
$20.88
Beta
0.49
52W High
$562.24
52W Low
$364.23
50-Day MA
$514.57
200-Day MA
$464.90
Dividend Yield
0.47%
Profit Margin
10.60%
Forward P/E
19.12
PEG Ratio
1.91

About Chemed Corp

Chemed Corporation provides hospice and hospice services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers across the United States. The company is headquartered in Cincinnati, Ohio.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.66B
Gross Profit (TTM)$892.52M
EBITDA$444.42M
Operating Margin15.10%
Return on Equity29.10%
Return on Assets14.30%
Revenue/Share (TTM)$197.53
Book Value$66.47
Price-to-Book8.03
Price-to-Sales (TTM)2.57
EV/Revenue2.729
EV/EBITDA15.97
Quarterly Earnings Growth (YoY)22.20%
Quarterly Revenue Growth (YoY)10.60%
Shares Outstanding$12.96M
Float$11.79M
% Insiders1.94%
% Institutions105.12%

Historical Volatility

HV 10-Day
36.10%
HV 20-Day
28.46%
HV 30-Day
24.56%
HV 60-Day
23.23%
HV Rank
57.9%

Volatility is currently expanding

Analyst Ratings

Consensus ($617.00 target)
2
Buy
3
Hold

Latest News

Chemed Corporation Declares Quarterly Dividend of 70 Cents

CINCINNATI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026.

GlobeNewsWire11/6/2026Neutral
Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference

CINCINNATI, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2026 Global Healthcare Conference on Monday, November 9, 2026, at approximately 8:45 a.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.

GlobeNewsWire11/2/2026Neutral
What Chemed (CHE) Said on Its Q3 Earnings Call

Chemed NYSE: CHE reported higher third-quarter revenue and adjusted earnings as growth at its VITAS hospice business offset margin pressure at Roto-Rooter from customer-acquisition and fuel costs.

MarketBeat10/29/2026Negative
Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript

Chemed Corporation ( CHE ) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDT Company Participants Holley Schmidt - Vice President & Assistant Controller Kevin McNamara - CEO, President & Director Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Joel Wherley - Executive VP and President & CEO of VITAS Healthcare Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Albert Rice - UBS Investment Bank, Research Division Presentation Operator Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Chemed Corporation Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

Seeking Alpha10/28/2026Neutral
Chemed Reports Third-Quarter 2026 Results

CINCINNATI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2026, versus the comparable prior-year period. Results for Quarter Ended September 30, 2026 Consolidated operating results: Revenue increased 10.6% to $690.9 million GAAP Diluted Earnings-per-Share (EPS) of $5.45, an increase of 22.2% Adjusted Diluted EPS of $6.75, an increase of 28.1% VITAS segment operating results: Net Patient Revenue of $457.4 million, an increase of 12.2% Average Daily Census (ADC) of 24,428, an increase of 9.4% Admissions of 18,995, an increase of 7.2% Net Income, excluding certain discrete items, of $70.8 million, an increase of 44.7% Adjusted EBITDA, excluding Medicare Cap, of $92.5 million, an increase of 31.4% Adjusted EBITDA margin, excluding Medicare Cap, of 20.2%, an increase of 318-basis points Roto-Rooter segment operating results: Revenue of $233.5 million, an increase of 7.5% Net Income, excluding certain discrete items, of $33.3 million, a decline of 1.8% Adjusted EBITDA of $48.2 million, a decline of 2.5% Adjusted EBITDA margin of 20.6%, a decline of 213-basis points VITAS VITAS net revenue was $457.4 million in the third quarter of 2026, which is an increase of 12.2% when compared to the prior-year period.

GlobeNewsWire10/27/2026Neutral
Roto-Rooter Buys Largest Franchisee Territory

CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise, serving a population of approximately 11 million people, for $60.6 million.

GlobeNewsWire9/16/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CHE and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026